论文信息 - Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer. - 字舞流文

Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer.

I. Vergote | G. Scambia | D. Dizon | S. McMeekin | A. Oaknin | J. Barter | A. Lisyanskaya | P. Mukhopadhyay | Sarah Ringuette | L. Manzyuk | J. Rosenberg